• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痘苗病毒的减毒以及对病毒持续存在期间被选择性修饰的结构蛋白的鉴定。

Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

作者信息

Paez E, Dallo S, Esteban M

出版信息

J Virol. 1987 Aug;61(8):2642-7. doi: 10.1128/JVI.61.8.2642-2647.1987.

DOI:10.1128/JVI.61.8.2642-2647.1987
PMID:3474420
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC255716/
Abstract

To investigate the genetic stability of vaccinia virus DNA, we have tested whether alterations occurred in the polypeptide composition of this complex virus during persistent infections. We found that variants isolated at various passages in Friend erythroleukemia cells persistently infected with vaccinia virus contained, in addition to an 8-megadalton (MDa) deletion on the left terminus of the viral genome, major alterations in the sizes of three structural proteins with molecular masses of about 39, 21, and 14 kDa. Alterations in isoelectric points were also observed in proteins of 48, 27, and 14 kDa. The 14-kDa protein is part of the virus envelope, and the variants increased the size of this protein from 0.5 to 3 kDa with increasing passage number. Alteration in size of the 14-kDa protein is a dominant trait since it appeared in the whole virus population by passage 48. With more passages, some variants were found to increase or decrease the size of a 39-kDa core protein by about 2 kDa and to decrease the size of an envelope protein of 21 kDa by about 2 kDa. These three proteins were immunogenic in mice and elicited a strong host immune response. Major alterations in the sizes of these proteins were prevented by continuous treatment of the persistently infected cultures with interferon. However, after interferon was removed, protein modifications appeared with increasing passage number. Generation of the 8-MDa deletion and alterations in the size of the 14-kDa protein correlated with a marked decrease in virulence of these variants. Our findings suggest that during virus persistence, specific mutations are introduced in the vaccinia virus genome that lead to protein alterations and to highly attenuated viruses.

摘要

为了研究痘苗病毒DNA的遗传稳定性,我们测试了这种复合病毒在持续感染期间其多肽组成是否发生改变。我们发现,从持续感染痘苗病毒的弗氏红白血病细胞的不同传代中分离出的变体,除了病毒基因组左末端有一个8兆道尔顿(MDa)的缺失外,三种分子量约为39、21和14 kDa的结构蛋白的大小也有重大改变。在48、27和14 kDa的蛋白质中也观察到了等电点的改变。14 kDa的蛋白质是病毒包膜的一部分,随着传代次数的增加,这些变体使该蛋白质的大小从0.5 kDa增加到3 kDa。14 kDa蛋白质大小的改变是一个显性特征,因为在第48代时它出现在整个病毒群体中。随着传代次数的增加,一些变体被发现使一种39 kDa的核心蛋白的大小增加或减少约2 kDa,并使一种21 kDa的包膜蛋白的大小减少约2 kDa。这三种蛋白质在小鼠中具有免疫原性,并引发强烈的宿主免疫反应。用干扰素持续处理持续感染的培养物可防止这些蛋白质大小的重大改变。然而,去除干扰素后,随着传代次数的增加,蛋白质修饰出现了。8-MDa缺失的产生和14 kDa蛋白质大小的改变与这些变体的毒力显著降低相关。我们的研究结果表明,在病毒持续存在期间,痘苗病毒基因组中引入了特定的突变,导致蛋白质改变并产生高度减毒的病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/255716/589533a65b84/jvirol00099-0305-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/255716/0ab506b40cda/jvirol00099-0304-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/255716/589533a65b84/jvirol00099-0305-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/255716/0ab506b40cda/jvirol00099-0304-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda1/255716/589533a65b84/jvirol00099-0305-a.jpg

相似文献

1
Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.痘苗病毒的减毒以及对病毒持续存在期间被选择性修饰的结构蛋白的鉴定。
J Virol. 1987 Aug;61(8):2642-7. doi: 10.1128/JVI.61.8.2642-2647.1987.
2
A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus.痘苗病毒的一种14K包膜蛋白在病毒与宿主细胞相互作用中起重要作用,在病毒持续存在期间会发生改变,并决定病毒的蚀斑大小表型。
Virology. 1987 Aug;159(2):423-32. doi: 10.1016/0042-6822(87)90481-8.
3
Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.在痘苗病毒DNA左末端产生一个显性的8兆道尔顿缺失。
Proc Natl Acad Sci U S A. 1985 May;82(10):3365-9. doi: 10.1073/pnas.82.10.3365.
4
Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.鉴定在痘苗病毒持续存在期间发生修饰的、细胞融合和病毒传播所需的病毒膜蛋白。
Virology. 1994 Jan;198(1):155-68. doi: 10.1006/viro.1994.1018.
5
Isolation and characterization of attenuated mutants of vaccinia virus.牛痘病毒减毒突变体的分离与鉴定
Virology. 1987 Aug;159(2):408-22. doi: 10.1016/0042-6822(87)90480-6.
6
Characterization of vaccinia virus deletion mutants isolated from persistently infected Friend erythroleukemia cells.从持续感染的弗氏红白血病细胞中分离出的痘苗病毒缺失突变体的特性分析。
Virus Res. 1989 Mar;12(3):239-50. doi: 10.1016/0168-1702(89)90042-7.
7
Stability of vaccinia virus DNA during persistent infections: accumulation of left-end deletions and of tandem repeats at both ends of the viral genome and prevention by interferon.痘苗病毒DNA在持续性感染期间的稳定性:病毒基因组两端左端缺失及串联重复序列的积累以及干扰素的预防作用
Virology. 1988 Mar;163(1):145-54. doi: 10.1016/0042-6822(88)90241-3.
8
Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.痘苗病毒基因的鉴定与特性分析,这些基因编码的蛋白质在动物体内具有高度抗原性,且在接种疫苗的人类中具有免疫优势。
J Virol. 1992 Jan;66(1):386-98. doi: 10.1128/JVI.66.1.386-398.1992.
9
Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.痘苗病毒一种39000道尔顿免疫显性蛋白的结构与功能研究
J Virol. 1987 Dec;61(12):3910-9. doi: 10.1128/JVI.61.12.3910-3919.1987.
10
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.用于产生安全重组病毒的高度减毒痘苗病毒突变体。
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1287-91. doi: 10.1073/pnas.86.4.1287.

引用本文的文献

1
The evolution of poxvirus vaccines.痘病毒疫苗的演变
Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726.
2
Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.减毒和复制型痘苗病毒株 M65 和 M101,具有不同的生物学和免疫原性,可作为针对病原体的潜在候选疫苗。
J Virol. 2013 Jun;87(12):6955-74. doi: 10.1128/JVI.03013-12. Epub 2013 Apr 17.
3
Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells.

本文引用的文献

1
Analysis of replicating vaccinia DNA in interferon-treated, virus-infected cells.在干扰素处理的、病毒感染细胞中对复制的痘苗病毒DNA的分析。
J Interferon Res. 1984 Spring;4(2):179-92. doi: 10.1089/jir.1984.4.179.
2
Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system.痘苗病毒对干扰素的抗性与病毒和干扰素系统之间的干扰现象有关。
Virology. 1984 Apr 15;134(1):12-28. doi: 10.1016/0042-6822(84)90268-x.
3
Interferon inhibits transformation of mouse cells by exogenous cellular or viral genes.
痘苗病毒包膜D8L蛋白与细胞表面硫酸软骨素结合,并介导细胞内成熟病毒粒子吸附到细胞上。
J Virol. 1999 Oct;73(10):8750-61. doi: 10.1128/JVI.73.10.8750-8761.1999.
4
A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate.A27L蛋白介导痘苗病毒与细胞表面硫酸乙酰肝素的相互作用。
J Virol. 1998 Feb;72(2):1577-85. doi: 10.1128/JVI.72.2.1577-1585.1998.
5
A vaccinia virus core protein, p39, is membrane associated.一种痘苗病毒核心蛋白p39与膜相关。
J Virol. 1996 Oct;70(10):6909-21. doi: 10.1128/JVI.70.10.6909-6921.1996.
6
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.痘苗病毒的组装:p14和p32掺入细胞内成熟病毒的膜中。
J Virol. 1995 Jun;69(6):3560-74. doi: 10.1128/JVI.69.6.3560-3574.1995.
7
Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.萤火虫荧光素酶基因在痘苗病毒中的表达:一种用于追踪病毒在感染动物组织中传播的高度敏感的基因标记物。
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1667-71. doi: 10.1073/pnas.85.5.1667.
8
Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.噬斑大小表型作为一种选择标记来产生痘苗病毒重组体。
J Virol. 1989 Feb;63(2):997-1001. doi: 10.1128/JVI.63.2.997-1001.1989.
9
Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.编码一种14千道尔顿融合蛋白的痘苗病毒基因的图谱及核苷酸序列。
J Virol. 1987 Nov;61(11):3550-4. doi: 10.1128/JVI.61.11.3550-3554.1987.
10
A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.痘苗病毒14000道尔顿包膜蛋白中Ala - 25突变为Asp的单点突变会导致大小变化,从而产生该病毒的小蚀斑大小表型。
J Virol. 1989 Nov;63(11):4507-14. doi: 10.1128/JVI.63.11.4507-4514.1989.
Nature. 1983;303(5916):433-5. doi: 10.1038/303433a0.
4
Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis.痘病毒的生物发生:血凝素产生与多核细胞增多之间的相互关系。
Virology. 1971 Dec;46(3):533-43. doi: 10.1016/0042-6822(71)90057-2.
5
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus.痘苗病毒中和单克隆抗体的分离与鉴定
J Virol. 1985 Nov;56(2):482-8. doi: 10.1128/JVI.56.2.482-488.1985.
6
Interferon inhibits marker rescue of vaccinia virus.
J Interferon Res. 1985 Spring;5(2):247-56. doi: 10.1089/jir.1985.5.247.
7
Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes.干扰素对病毒基因和细胞基因所致遗传转化及致癌转化的抑制作用。
J Virol. 1985 Apr;54(1):229-32. doi: 10.1128/JVI.54.1.229-232.1985.
8
Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.干扰素可防止痘苗病毒DNA左端自发缺失的产生。
J Virol. 1985 Oct;56(1):75-84. doi: 10.1128/JVI.56.1.75-84.1985.
9
Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus.前列腺素和非甾体抗炎药在牛痘病毒致病性中的作用。
J Gen Virol. 1987 Feb;68 ( Pt 2):593-600. doi: 10.1099/0022-1317-68-2-593.
10
A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.痘苗病毒的一种14000道尔顿的包膜蛋白参与细胞融合并形成共价连接的三聚体。
J Virol. 1987 Feb;61(2):395-404. doi: 10.1128/JVI.61.2.395-404.1987.